-
1
-
-
67651065502
-
Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies
-
Abdel-Wahab O., Mullally A., Hedvat C., Garcia-Manero G., Patel J., Wadleigh M., Malinge S., Yao J., Kilpivaara O., Bhat R., et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood 2009, 114:144-147.
-
(2009)
Blood
, vol.114
, pp. 144-147
-
-
Abdel-Wahab, O.1
Mullally, A.2
Hedvat, C.3
Garcia-Manero, G.4
Patel, J.5
Wadleigh, M.6
Malinge, S.7
Yao, J.8
Kilpivaara, O.9
Bhat, R.10
-
2
-
-
76549109434
-
Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias
-
Abdel-Wahab O., Manshouri T., Patel J., Harris K., Yao J., Hedvat C., Heguy A., Bueso-Ramos C., Kantarjian H., Levine R.L., Verstovsek S. Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias. Cancer Res. 2010, 70:447-452.
-
(2010)
Cancer Res.
, vol.70
, pp. 447-452
-
-
Abdel-Wahab, O.1
Manshouri, T.2
Patel, J.3
Harris, K.4
Yao, J.5
Hedvat, C.6
Heguy, A.7
Bueso-Ramos, C.8
Kantarjian, H.9
Levine, R.L.10
Verstovsek, S.11
-
3
-
-
77950977381
-
Two routes to leukemic transformation following a JAK2 mutation-positive myeloproliferative neoplasm
-
Beer P.A., Delhommeau F., Lecouedic J.P., Dawson M.A., Chen E., Bareford D., Kusec R., McMullin M.F., Harrison C.N., Vannucchi A.M., et al. Two routes to leukemic transformation following a JAK2 mutation-positive myeloproliferative neoplasm. Blood 2010, 115:2891-2900.
-
(2010)
Blood
, vol.115
, pp. 2891-2900
-
-
Beer, P.A.1
Delhommeau, F.2
Lecouedic, J.P.3
Dawson, M.A.4
Chen, E.5
Bareford, D.6
Kusec, R.7
McMullin, M.F.8
Harrison, C.N.9
Vannucchi, A.M.10
-
4
-
-
74249096163
-
Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias
-
Couronné L., Lippert E., Andrieux J., Kosmider O., Radford-Weiss I., Penther D., Dastugue N., Mugneret F., Lafage M., Gachard N., et al. Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias. Leukemia 2010, 24:201-203.
-
(2010)
Leukemia
, vol.24
, pp. 201-203
-
-
Couronné, L.1
Lippert, E.2
Andrieux, J.3
Kosmider, O.4
Radford-Weiss, I.5
Penther, D.6
Dastugue, N.7
Mugneret, F.8
Lafage, M.9
Gachard, N.10
-
5
-
-
0346100567
-
Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors
-
Cozzio A., Passegué E., Ayton P.M., Karsunky H., Cleary M.L., Weissman I.L. Similar MLL-associated leukemias arising from self-renewing stem cells and short-lived myeloid progenitors. Genes Dev. 2003, 17:3029-3035.
-
(2003)
Genes Dev.
, vol.17
, pp. 3029-3035
-
-
Cozzio, A.1
Passegué, E.2
Ayton, P.M.3
Karsunky, H.4
Cleary, M.L.5
Weissman, I.L.6
-
6
-
-
66249137734
-
Mutation in TET2 in myeloid cancers
-
Delhommeau F., Dupont S., Della Valle V., James C., Trannoy S., Massé A., Kosmider O., Le Couedic J.P., Robert F., Alberdi A., et al. Mutation in TET2 in myeloid cancers. N. Engl. J. Med. 2009, 360:2289-2301.
-
(2009)
N. Engl. J. Med.
, vol.360
, pp. 2289-2301
-
-
Delhommeau, F.1
Dupont, S.2
Della Valle, V.3
James, C.4
Trannoy, S.5
Massé, A.6
Kosmider, O.7
Le Couedic, J.P.8
Robert, F.9
Alberdi, A.10
-
7
-
-
58149380742
-
Stem cell concepts renew cancer research
-
Dick J.E. Stem cell concepts renew cancer research. Blood 2008, 112:4793-4807.
-
(2008)
Blood
, vol.112
, pp. 4793-4807
-
-
Dick, J.E.1
-
8
-
-
70349836510
-
The role of PLZF in human myeloid development
-
Dick J.E., Doulatov S. The role of PLZF in human myeloid development. Ann. N. Y. Acad. Sci. 2009, 1176:150-153.
-
(2009)
Ann. N. Y. Acad. Sci.
, vol.1176
, pp. 150-153
-
-
Dick, J.E.1
Doulatov, S.2
-
9
-
-
78650019179
-
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation
-
Figueroa M.E., Abdel-Wahab O., Lu C., Ward P.S., Patel J., Shih A., Li Y., Bhagwat N., Vasanthakumar A., Fernandez H.F., et al. Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell 2010, 18:553-567.
-
(2010)
Cancer Cell
, vol.18
, pp. 553-567
-
-
Figueroa, M.E.1
Abdel-Wahab, O.2
Lu, C.3
Ward, P.S.4
Patel, J.5
Shih, A.6
Li, Y.7
Bhagwat, N.8
Vasanthakumar, A.9
Fernandez, H.F.10
-
10
-
-
78651416188
-
Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia
-
Goardon N., Marchi E., Atzberger A., Quek L., Schuh A., Soneji S., Woll P., Mead A., Alford K.A., Rout R., et al. Coexistence of LMPP-like and GMP-like leukemia stem cells in acute myeloid leukemia. Cancer Cell 2011, 19:138-152.
-
(2011)
Cancer Cell
, vol.19
, pp. 138-152
-
-
Goardon, N.1
Marchi, E.2
Atzberger, A.3
Quek, L.4
Schuh, A.5
Soneji, S.6
Woll, P.7
Mead, A.8
Alford, K.A.9
Rout, R.10
-
11
-
-
19944385935
-
MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors
-
Huntly B.J., Shigematsu H., Deguchi K., Lee B.H., Mizuno S., Duclos N., Rowan R., Amaral S., Curley D., Williams I.R., et al. MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitors. Cancer Cell 2004, 6:587-596.
-
(2004)
Cancer Cell
, vol.6
, pp. 587-596
-
-
Huntly, B.J.1
Shigematsu, H.2
Deguchi, K.3
Lee, B.H.4
Mizuno, S.5
Duclos, N.6
Rowan, R.7
Amaral, S.8
Curley, D.9
Williams, I.R.10
-
12
-
-
77956189495
-
Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification
-
Ito S., D'Alessio A.C., Taranova O.V., Hong K., Sowers L.C., Zhang Y. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 2010, 466:1129-1133.
-
(2010)
Nature
, vol.466
, pp. 1129-1133
-
-
Ito, S.1
D'Alessio, A.C.2
Taranova, O.V.3
Hong, K.4
Sowers, L.C.5
Zhang, Y.6
-
13
-
-
77949453079
-
The 2008 WHO classification of lymphomas: implications for clinical practice and translational research
-
Jaffe E.S. The 2008 WHO classification of lymphomas: implications for clinical practice and translational research. Hematology Am. Soc. Hematol. Educ. Program 2009, 523-531.
-
(2009)
Hematology Am. Soc. Hematol. Educ. Program
, pp. 523-531
-
-
Jaffe, E.S.1
-
14
-
-
67650588639
-
Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms
-
Jankowska A.M., Szpurka H., Tiu R.V., Makishima H., Afable M., Huh J., O'Keefe C.L., Ganetzky R., McDevitt M.A., Maciejewski J.P. Loss of heterozygosity 4q24 and TET2 mutations associated with myelodysplastic/myeloproliferative neoplasms. Blood 2009, 113:6403-6410.
-
(2009)
Blood
, vol.113
, pp. 6403-6410
-
-
Jankowska, A.M.1
Szpurka, H.2
Tiu, R.V.3
Makishima, H.4
Afable, M.5
Huh, J.6
O'Keefe, C.L.7
Ganetzky, R.8
McDevitt, M.A.9
Maciejewski, J.P.10
-
15
-
-
77950622296
-
Functional classification of peripheral T-cell lymphomas as an approach to improve outcome prediction and therapy selection
-
Jones D. Functional classification of peripheral T-cell lymphomas as an approach to improve outcome prediction and therapy selection. Semin. Hematol. 2010, 47(Suppl 1):S1-S4.
-
(2010)
Semin. Hematol.
, vol.47
, Issue.SUPPL 1
-
-
Jones, D.1
-
16
-
-
78650175023
-
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
-
Ko M., Huang Y., Jankowska A.M., Pape U.J., Tahiliani M., Bandukwala H.S., An J., Lamperti E.D., Koh K.P., Ganetzky R., et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010, 468:839-843.
-
(2010)
Nature
, vol.468
, pp. 839-843
-
-
Ko, M.1
Huang, Y.2
Jankowska, A.M.3
Pape, U.J.4
Tahiliani, M.5
Bandukwala, H.S.6
An, J.7
Lamperti, E.D.8
Koh, K.P.9
Ganetzky, R.10
-
17
-
-
78650175023
-
Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
-
Ko M., Huang Y., Jankowska A.M., Pape U.J., Tahiliani M., Bandukwala H.S., An J., Lamperti E.D., Koh K.P., Ganetzky R., et al. Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2. Nature 2010, 468:839-843.
-
(2010)
Nature
, vol.468
, pp. 839-843
-
-
Ko, M.1
Huang, Y.2
Jankowska, A.M.3
Pape, U.J.4
Tahiliani, M.5
Bandukwala, H.S.6
An, J.7
Lamperti, E.D.8
Koh, K.P.9
Ganetzky, R.10
-
18
-
-
77956237515
-
Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1
-
Kohlmann A., Grossmann V., Klein H.U., Schindela S., Weiss T., Kazak B., Dicker F., Schnittger S., Dugas M., Kern W., et al. Next-generation sequencing technology reveals a characteristic pattern of molecular mutations in 72.8% of chronic myelomonocytic leukemia by detecting frequent alterations in TET2, CBL, RAS, and RUNX1. J. Clin. Oncol. 2010, 28:3858-3865.
-
(2010)
J. Clin. Oncol.
, vol.28
, pp. 3858-3865
-
-
Kohlmann, A.1
Grossmann, V.2
Klein, H.U.3
Schindela, S.4
Weiss, T.5
Kazak, B.6
Dicker, F.7
Schnittger, S.8
Dugas, M.9
Kern, W.10
-
19
-
-
79551587102
-
Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells
-
Koh K.P., Yabuuchi A., Rao S., Huang Y., Cunniff K., Nardone J., Laiho A., Tahiliani M., Sommer C.A., Mostoslavsky G., et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 2011, 8:200-213.
-
(2011)
Cell Stem Cell
, vol.8
, pp. 200-213
-
-
Koh, K.P.1
Yabuuchi, A.2
Rao, S.3
Huang, Y.4
Cunniff, K.5
Nardone, J.6
Laiho, A.7
Tahiliani, M.8
Sommer, C.A.9
Mostoslavsky, G.10
-
20
-
-
70350438115
-
TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)
-
Groupe Francophone des Myélodysplasies
-
Kosmider O., Gelsi-Boyer V., Cheok M., Grabar S., Della-Valle V., Picard F., Viguié F., Quesnel B., Beyne-Rauzy O., Solary E., et al. TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs). Blood 2009, 114:3285-3291. Groupe Francophone des Myélodysplasies.
-
(2009)
Blood
, vol.114
, pp. 3285-3291
-
-
Kosmider, O.1
Gelsi-Boyer, V.2
Cheok, M.3
Grabar, S.4
Della-Valle, V.5
Picard, F.6
Viguié, F.7
Quesnel, B.8
Beyne-Rauzy, O.9
Solary, E.10
-
21
-
-
73149094518
-
TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia
-
Groupe Francophone des Myélodysplasies
-
Kosmider O., Gelsi-Boyer V., Ciudad M., Racoeur C., Jooste V., Vey N., Quesnel B., Fenaux P., Bastie J.N., Beyne-Rauzy O., et al. TET2 gene mutation is a frequent and adverse event in chronic myelomonocytic leukemia. Haematologica 2009, 94:1676-1681. Groupe Francophone des Myélodysplasies.
-
(2009)
Haematologica
, vol.94
, pp. 1676-1681
-
-
Kosmider, O.1
Gelsi-Boyer, V.2
Ciudad, M.3
Racoeur, C.4
Jooste, V.5
Vey, N.6
Quesnel, B.7
Fenaux, P.8
Bastie, J.N.9
Beyne-Rauzy, O.10
-
22
-
-
66149123748
-
The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain
-
Kriaucionis S., Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 2009, 324:929-930.
-
(2009)
Science
, vol.324
, pp. 929-930
-
-
Kriaucionis, S.1
Heintz, N.2
-
23
-
-
67649876132
-
Acquired mutations in TET2 are common in myelodysplastic syndromes
-
Langemeijer S.M., Kuiper R.P., Berends M., Knops R., Aslanyan M.G., Massop M., Stevens-Linders E., van Hoogen P., van Kessel A.G., Raymakers R.A., et al. Acquired mutations in TET2 are common in myelodysplastic syndromes. Nat. Genet. 2009, 41:838-842.
-
(2009)
Nat. Genet.
, vol.41
, pp. 838-842
-
-
Langemeijer, S.M.1
Kuiper, R.P.2
Berends, M.3
Knops, R.4
Aslanyan, M.G.5
Massop, M.6
Stevens-Linders, E.7
van Hoogen, P.8
van Kessel, A.G.9
Raymakers, R.A.10
-
24
-
-
78649906060
-
DNMT3A mutations in acute myeloid leukemia
-
Ley T.J., Ding L., Walter M.J., McLellan M.D., Lamprecht T., Larson D.E., Kandoth C., Payton J.E., Baty J., Welch J., et al. DNMT3A mutations in acute myeloid leukemia. N. Engl. J. Med. 2010, 363:2424-2433.
-
(2010)
N. Engl. J. Med.
, vol.363
, pp. 2424-2433
-
-
Ley, T.J.1
Ding, L.2
Walter, M.J.3
McLellan, M.D.4
Lamprecht, T.5
Larson, D.E.6
Kandoth, C.7
Payton, J.E.8
Baty, J.9
Welch, J.10
-
25
-
-
77956513784
-
Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission
-
Nibourel O., Kosmider O., Cheok M., Boissel N., Renneville A., Philippe N., Dombret H., Dreyfus F., Quesnel B., Geffroy S., et al. Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission. Blood 2010, 116:1132-1135.
-
(2010)
Blood
, vol.116
, pp. 1132-1135
-
-
Nibourel, O.1
Kosmider, O.2
Cheok, M.3
Boissel, N.4
Renneville, A.5
Philippe, N.6
Dombret, H.7
Dreyfus, F.8
Quesnel, B.9
Geffroy, S.10
-
26
-
-
70149101696
-
Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms
-
French Group of Familial Myeloproliferative Disorders
-
Saint-Martin C., Leroy G., Delhommeau F., Panelatti G., Dupont S., James C., Plo I., Bordessoule D., Chomienne C., Delannoy A., et al. Analysis of the ten-eleven translocation 2 (TET2) gene in familial myeloproliferative neoplasms. Blood 2009, 114:1628-1632. French Group of Familial Myeloproliferative Disorders.
-
(2009)
Blood
, vol.114
, pp. 1628-1632
-
-
Saint-Martin, C.1
Leroy, G.2
Delhommeau, F.3
Panelatti, G.4
Dupont, S.5
James, C.6
Plo, I.7
Bordessoule, D.8
Chomienne, C.9
Delannoy, A.10
-
27
-
-
77950388949
-
Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms
-
Schaub F.X., Looser R., Li S., Hao-Shen H., Lehmann T., Tichelli A., Skoda R.C. Clonal analysis of TET2 and JAK2 mutations suggests that TET2 can be a late event in the progression of myeloproliferative neoplasms. Blood 2010, 115:2003-2007.
-
(2010)
Blood
, vol.115
, pp. 2003-2007
-
-
Schaub, F.X.1
Looser, R.2
Li, S.3
Hao-Shen, H.4
Lehmann, T.5
Tichelli, A.6
Skoda, R.C.7
-
28
-
-
66149146320
-
Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1
-
Tahiliani M., Koh K.P., Shen Y., Pastor W.A., Bandukwala H., Brudno Y., Agarwal S., Iyer L.M., Liu D.R., Aravind L., Rao A. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009, 324:930-935.
-
(2009)
Science
, vol.324
, pp. 930-935
-
-
Tahiliani, M.1
Koh, K.P.2
Shen, Y.3
Pastor, W.A.4
Bandukwala, H.5
Brudno, Y.6
Agarwal, S.7
Iyer, L.M.8
Liu, D.R.9
Aravind, L.10
Rao, A.11
-
29
-
-
67349145955
-
Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates
-
Tefferi A., Levine R.L., Lim K.H., Abdel-Wahab O., Lasho T.L., Patel J., Finke C.M., Mullally A., Li C.Y., Pardanani A., Gilliland D.G. Frequent TET2 mutations in systemic mastocytosis: clinical, KITD816V and FIP1L1-PDGFRA correlates. Leukemia 2009, 23:900-904.
-
(2009)
Leukemia
, vol.23
, pp. 900-904
-
-
Tefferi, A.1
Levine, R.L.2
Lim, K.H.3
Abdel-Wahab, O.4
Lasho, T.L.5
Patel, J.6
Finke, C.M.7
Mullally, A.8
Li, C.Y.9
Pardanani, A.10
Gilliland, D.G.11
-
30
-
-
67650924270
-
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
-
Tefferi A., Lim K.H., Abdel-Wahab O., Lasho T.L., Patel J., Patnaik M.M., Hanson C.A., Pardanani A., Gilliland D.G., Levine R.L. Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML. Leukemia 2009, 23:1343-1345.
-
(2009)
Leukemia
, vol.23
, pp. 1343-1345
-
-
Tefferi, A.1
Lim, K.H.2
Abdel-Wahab, O.3
Lasho, T.L.4
Patel, J.5
Patnaik, M.M.6
Hanson, C.A.7
Pardanani, A.8
Gilliland, D.G.9
Levine, R.L.10
-
31
-
-
67650924270
-
Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML
-
Tefferi A., Lim K.H., Abdel-Wahab O., Lasho T.L., Patel J., Patnaik M.M., Hanson C.A., Pardanani A., Gilliland D.G., Levine R.L. Detection of mutant TET2 in myeloid malignancies other than myeloproliferative neoplasms: CMML, MDS, MDS/MPN and AML. Leukemia 2009, 23:1343-1345.
-
(2009)
Leukemia
, vol.23
, pp. 1343-1345
-
-
Tefferi, A.1
Lim, K.H.2
Abdel-Wahab, O.3
Lasho, T.L.4
Patel, J.5
Patnaik, M.M.6
Hanson, C.A.7
Pardanani, A.8
Gilliland, D.G.9
Levine, R.L.10
-
32
-
-
67349124376
-
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
-
Tefferi A., Pardanani A., Lim K.H., Abdel-Wahab O., Lasho T.L., Patel J., Gangat N., Finke C.M., Schwager S., Mullally A., et al. TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis. Leukemia 2009, 23:905-911.
-
(2009)
Leukemia
, vol.23
, pp. 905-911
-
-
Tefferi, A.1
Pardanani, A.2
Lim, K.H.3
Abdel-Wahab, O.4
Lasho, T.L.5
Patel, J.6
Gangat, N.7
Finke, C.M.8
Schwager, S.9
Mullally, A.10
-
33
-
-
23744440061
-
Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement?
-
Viguié F., Aboura A., Bouscary D., Ramond S., Delmer A., Tachdjian G., Marie J.P., Casadevall N. Common 4q24 deletion in four cases of hematopoietic malignancy: early stem cell involvement?. Leukemia 2005, 19:1411-1415.
-
(2005)
Leukemia
, vol.19
, pp. 1411-1415
-
-
Viguié, F.1
Aboura, A.2
Bouscary, D.3
Ramond, S.4
Delmer, A.5
Tachdjian, G.6
Marie, J.P.7
Casadevall, N.8
|